Clinical use of rectal indomethacin suppositories. 1968

J S Johnson, and M H Johnson

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal

Related Publications

J S Johnson, and M H Johnson
March 1975, Lancet (London, England),
J S Johnson, and M H Johnson
December 1967, La Clinica terapeutica,
J S Johnson, and M H Johnson
April 1986, Journal of the American Geriatrics Society,
J S Johnson, and M H Johnson
June 1965, British medical journal,
J S Johnson, and M H Johnson
May 1965, British medical journal,
J S Johnson, and M H Johnson
January 1981, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
J S Johnson, and M H Johnson
April 1959, American journal of proctology,
J S Johnson, and M H Johnson
July 1975, Journal of postgraduate medicine,
J S Johnson, and M H Johnson
June 1984, Journal of pharmacobio-dynamics,
J S Johnson, and M H Johnson
November 1985, Acta pharmacologica et toxicologica,
Copied contents to your clipboard!